Article

Page 87

Article

Treatment of Severe Depression

January 31, 2000

Michael E. Thase

Article

Schizoaffective Disorder: A Form of Schizophrenia or Affective Disorder?

December 31, 1999

Jovier D. Evans, Robert K. Heaton, Jane S. Paulsen, et al

Article

Some Adverse Effects of Antipsychotics: Prevention and Treatment

December 1, 1999

Malcolm Lader

Article

Clozapine: The Commitment to Patient Safety

December 1, 1999

Larry D. Alphs, Ravi Anand

Article

Clozapine: A Comparison With Other Novel Antipsychotics

December 1, 1999

W. Wolfgang Fleischhacker

Article

The Effects of Clozapine on Aggression and Substance Abuse in Schizophrenic Patients

December 1, 1999

Jan Volavka

Article

The Effects of Clozapine on Cognitive Functioning in Schizophrenia

December 1, 1999

Susan R. McGurk

Article

The Evolving Definition of Treatment Resistance

December 1, 1999

Joseph Peuskens

Article

A Historical Perspective of Clozapine

December 1, 1999

Hanns Hippius

Article

Introduction. Treatment-Resistant Schizophrenia and Beyond: Current Concepts and Future Prospects.

December 1, 1999

Article

Management Strategies for the Treatment of Schizophrenia

December 1, 1999

John M. Kane

Article

Optimizing Clozapine Treatment

December 1, 1999

Dieter Naber

Article

Pathophysiologic Mechanisms in the Pathogenesis and Clinical Course of Schizophrenia

December 1, 1999

Jeffrey A. Lieberman

Article

Suicide and Schizophrenia: Clozapine and the InterSePT Study

December 1, 1999

Herbert Y. Meltzer

Article

Bright Light Therapy: Side Effects and Benefits Across the Symptom Spectrum

November 30, 1999

Michael Terman, Jiuan Su Terman

Article

Critical Overview: Adverse Cutaneous Reactions to Psychotropic Medications

October 31, 1999

Arash Kimyai-Asadi, James C. Harris, Hossein C. Nousari

Article

D2 and 5-HT2 Receptor Effects of Antipsychotics: Bridging Basic and Clinical Findings Using PET

October 1, 1999

Gary Remington, Shitij Kapur

Article

Does Loxapine Have "Atypical" Properties? Clinical Evidence

October 1, 1999

William M. Glazer

Article

Introduction. What Makes an Antipsychotic Atypical?

October 1, 1999

Stephen M. Stahl

Article

Low-Dose Loxapine in the Treatment of Schizophrenia: Is It More Effective and More "Atypical" Than Standard-Dose Loxapine?

October 1, 1999

Herbert Y. Meltzer, Karuna Jayathilake

Article

Pharmacologic and Pharmacokinetic Considerations in Choosing an Antipsychotic

October 1, 1999

Larry Ereshefsky

Article

Receptor Pharmacology of Neuroleptics: Relation to Clinical Effects

October 1, 1999

Elliott Richelson

Article

The Role of Typical and Atypical Antipsychotic Medications in the Management of Agitation and Aggression

October 1, 1999

Peter F. Buckley

Article

Selecting an Atypical Antipsychotic by Combining Clinical Experience With Guidelines From Clinical Trials

October 1, 1999

Stephen M. Stahl

« 1 … 85 86 87 88 89 … 107 »

Article

Treatment of Severe Depression

Schizoaffective Disorder: A Form of Schizophrenia or Affective Disorder?

Some Adverse Effects of Antipsychotics: Prevention and Treatment

Clozapine: The Commitment to Patient Safety

Clozapine: A Comparison With Other Novel Antipsychotics

The Effects of Clozapine on Aggression and Substance Abuse in Schizophrenic Patients

The Effects of Clozapine on Cognitive Functioning in Schizophrenia

The Evolving Definition of Treatment Resistance

A Historical Perspective of Clozapine

Introduction. Treatment-Resistant Schizophrenia and Beyond: Current Concepts and Future Prospects.

Management Strategies for the Treatment of Schizophrenia

Optimizing Clozapine Treatment

Pathophysiologic Mechanisms in the Pathogenesis and Clinical Course of Schizophrenia

Suicide and Schizophrenia: Clozapine and the InterSePT Study

Bright Light Therapy: Side Effects and Benefits Across the Symptom Spectrum

Critical Overview: Adverse Cutaneous Reactions to Psychotropic Medications

D2 and 5-HT2 Receptor Effects of Antipsychotics: Bridging Basic and Clinical Findings Using PET

Does Loxapine Have "Atypical" Properties? Clinical Evidence

Introduction. What Makes an Antipsychotic Atypical?

Low-Dose Loxapine in the Treatment of Schizophrenia: Is It More Effective and More "Atypical" Than Standard-Dose Loxapine?

Pharmacologic and Pharmacokinetic Considerations in Choosing an Antipsychotic

Receptor Pharmacology of Neuroleptics: Relation to Clinical Effects

The Role of Typical and Atypical Antipsychotic Medications in the Management of Agitation and Aggression

Selecting an Atypical Antipsychotic by Combining Clinical Experience With Guidelines From Clinical Trials

ELSEWHERE:

FOLLOW US:

Article

Treatment of Severe Depression

Schizoaffective Disorder: A Form of Schizophrenia or Affective Disorder?

Some Adverse Effects of Antipsychotics: Prevention and Treatment

Clozapine: The Commitment to Patient Safety

Clozapine: A Comparison With Other Novel Antipsychotics

The Effects of Clozapine on Aggression and Substance Abuse in Schizophrenic Patients

The Effects of Clozapine on Cognitive Functioning in Schizophrenia

The Evolving Definition of Treatment Resistance

A Historical Perspective of Clozapine

Introduction. Treatment-Resistant Schizophrenia and Beyond: Current Concepts and Future Prospects.

Management Strategies for the Treatment of Schizophrenia

Optimizing Clozapine Treatment

Pathophysiologic Mechanisms in the Pathogenesis and Clinical Course of Schizophrenia

Suicide and Schizophrenia: Clozapine and the InterSePT Study

Bright Light Therapy: Side Effects and Benefits Across the Symptom Spectrum

Critical Overview: Adverse Cutaneous Reactions to Psychotropic Medications

D2 and 5-HT2 Receptor Effects of Antipsychotics: Bridging Basic and Clinical Findings Using PET

Does Loxapine Have "Atypical" Properties? Clinical Evidence

Introduction. What Makes an Antipsychotic Atypical?

Low-Dose Loxapine in the Treatment of Schizophrenia: Is It More Effective and More "Atypical" Than Standard-Dose Loxapine?

Pharmacologic and Pharmacokinetic Considerations in Choosing an Antipsychotic

Receptor Pharmacology of Neuroleptics: Relation to Clinical Effects

The Role of Typical and Atypical Antipsychotic Medications in the Management of Agitation and Aggression

Selecting an Atypical Antipsychotic by Combining Clinical Experience With Guidelines From Clinical Trials

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles